312 related articles for article (PubMed ID: 25081899)
21. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
23. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
26. Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer.
Hemminki K; Li X; Försti A; Sundquist J; Sundquist K
Ann Oncol; 2014 Feb; 25(2):511-8. PubMed ID: 24406424
[TBL] [Abstract][Full Text] [Related]
27. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
Simard JF; Baecklund F; Chang ET; Baecklund E; Hjalgrim H; -Olov Adami H; Glimelius B; Smedby KE
Int J Cancer; 2013 Jun; 132(11):2659-66. PubMed ID: 23160780
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.
Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Korean J Intern Med; 2016 Sep; 31(5):944-52. PubMed ID: 27384438
[TBL] [Abstract][Full Text] [Related]
29. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune disease and subsequent digestive tract cancer by histology.
Hemminki K; Liu X; Ji J; Sundquist J; Sundquist K
Ann Oncol; 2012 Apr; 23(4):927-33. PubMed ID: 21810731
[TBL] [Abstract][Full Text] [Related]
31. Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden.
Li X; Sundquist J; Nymberg V; Sundquist K
Eur Heart J Qual Care Clin Outcomes; 2022 Jan; 8(1):79-85. PubMed ID: 34152406
[TBL] [Abstract][Full Text] [Related]
32. Risk of incident autoimmune diseases in patients with thymectomy.
Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Kuo PI; Lin YC; Chen JH; Chang CC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1072-1082. PubMed ID: 32478484
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M
Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432
[TBL] [Abstract][Full Text] [Related]
35. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.
Zhang Y; Holford TR; Leaderer B; Zahm SH; Boyle P; Morton LM; Zhang B; Zou K; Flynn S; Tallini G; Owens PH; Zheng T
Cancer Causes Control; 2004 May; 15(4):419-28. PubMed ID: 15141141
[TBL] [Abstract][Full Text] [Related]
36. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Lancet; 2012 Jan; 379(9812):244-9. PubMed ID: 22119579
[TBL] [Abstract][Full Text] [Related]
37. Altered immunity as a risk factor for non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Cozen W
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):405-8. PubMed ID: 17337643
[TBL] [Abstract][Full Text] [Related]
38. Neighborhood Deprivation and Risks of Autoimmune Disorders: A National Cohort Study in Sweden.
Li X; Sundquist J; Hamano T; Sundquist K
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31601008
[No Abstract] [Full Text] [Related]
39. Bidirectional Relationship Between Primary Sjögren Syndrome and Non-Hodgkin Lymphoma: A Nationwide Taiwanese Population-based Study.
Wang LH; Wang WM; Lin CY; Lin SH; Shieh CC
J Rheumatol; 2020 Sep; 47(9):1374-1378. PubMed ID: 31941803
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin lymphoma in Romania: a single-centre experience.
Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
